Guadalquiver, Annamae D.

HRN: 18-00-55  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2025
CEFUROXIME 500MG (TAB)
09/19/2025
09/26/2025
PO
500mg
BID X 7 Days
Thickly MSAF
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines